Literature DB >> 17962777

Synthesis, molecular structure and characterization of allylic derivatives of 6-amino-3-methyl-1,2,4-triazolo[3,4-f][1,2,4]-triazin-8(7H)-one.

Long-Chih Hwang1, Shin-Yi Jane, Hsing-Yi Lai, Chun-Hsien Tu, Gene-Hsiang Lee.   

Abstract

1-Allyl- (2) and 7-allyl-6-amino-3-methyl-1,2,4-triazolo[3,4-f][1,2,4]triazin-8(7H)-one (3) were obtained via the 18-crown-6-ether catalyzed room temperature reaction of 6-amino-3-methyl-1,2,4-triazolo[3,4-f][1,2,4]triazin-8(7H)-one (1) with potassium carbonate and allyl bromide in dry acetone. The structures of these two derivatives were verified by 2D-NMR measurements, including gHSQC and gHMBC measurements. The minor compound 2 may possess aromatic character. A single crystal X-ray diffraction experiment indicated that the major compound 3 crystallizes from dimethyl sulfoxide in the monoclinic space group P2(1)/n and its molecular structure includes an attached dimethylsulfoxide molecule, resulting in the molecular formula C(10)H(16)N(6)O(2)S. Molecular structures of 3 are linked by extensive intermolecular N-H...N hydrogen bonding [graph set C(1)(1)(7)]. 1 Each molecule is attached to the dimethyl sulfoxide oxygen via N-H...O intermolecular hydrogen bonding. The structure is further stabilized by pi-pi stacking interactions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17962777      PMCID: PMC6148529          DOI: 10.3390/11060444

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  19 in total

1.  Synthesis of heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anticancer drugs: Part I.

Authors:  R M Abdel-Rahman; J M Morsy; F Hanafy; H A Amene
Journal:  Pharmazie       Date:  1999-05       Impact factor: 1.267

Review 2.  Role of uncondensed 1,2,4-triazine compounds and related heterobicyclic systems as therapeutic agents--a review.

Authors:  R M Abdel-Rahman
Journal:  Pharmazie       Date:  2001-01       Impact factor: 1.267

3.  Synthesis, anti-HIV and anticancer activities of new 4-(2-mercaptobenzenesulfonyl)perhydro-1,2,4-triazin-3-ones.

Authors:  E Pomarnacka
Journal:  Acta Pol Pharm       Date:  1998 Nov-Dec       Impact factor: 0.330

4.  Crystal structure of 6-amino-3-ethyl-1,2,4-triazolo[3,4-f][1,2,4]triazin-8(7H)-one.

Authors:  Long-Chih Hwang; Chun-Hsien Tu; Jung-Hui Wang; Gene-Hsiang Lee; Yu Wang
Journal:  Anal Sci       Date:  2002-07       Impact factor: 2.081

5.  Identification of a novel class of orally active pyrimido[5,4-3][1,2,4]triazine-5,7-diamine-based hypoglycemic agents with protein tyrosine phosphatase inhibitory activity.

Authors:  Kevin R Guertin; Lina Setti; Lida Qi; Rachel M Dunsdon; Brian W Dymock; Philip S Jones; Hilary Overton; Mathew Taylor; Glyn Williams; Joseph A Sergi; Karen Wang; Ying Peng; Marcia Renzetti; Rogely Boyce; Fiorenza Falcioni; Ralph Garippa; Andrée R Olivier
Journal:  Bioorg Med Chem Lett       Date:  2003-09-01       Impact factor: 2.823

6.  Synthesis and SAR of 4-(3-hydroxyphenylamino)pyrrolo[2,1-f][1,2,4]triazine based VEGFR-2 kinase inhibitors.

Authors:  Robert M Borzilleri; Zhen-Wei Cai; Christopher Ellis; Joseph Fargnoli; Aberra Fura; Tracy Gerhardt; Bindu Goyal; John T Hunt; Steven Mortillo; Ligang Qian; John Tokarski; Viral Vyas; Barri Wautlet; Xioping Zheng; Rajeev S Bhide
Journal:  Bioorg Med Chem Lett       Date:  2005-03-01       Impact factor: 2.823

7.  Design, synthesis, and evaluation of orally active 4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines as dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 inhibitors.

Authors:  Robert M Borzilleri; Xiaoping Zheng; Ligang Qian; Christopher Ellis; Zhen-wei Cai; Barri S Wautlet; Steve Mortillo; Robert Jeyaseelan; Daniel W Kukral; Aberra Fura; Amrita Kamath; Viral Vyas; John S Tokarski; Joel C Barrish; John T Hunt; Louis J Lombardo; Joseph Fargnoli; Rajeev S Bhide
Journal:  J Med Chem       Date:  2005-06-16       Impact factor: 7.446

8.  Synthesis and molecular structure of 6-amino-3-benzylmercapto-1,2,4-triazolo[3,4-f][1,2,4]triazin-8(7H)-one.

Authors:  Long-Chih Hwang; Chun-Hsie Tu; Jung-Hui Wang; Gene-Hsiang Lee
Journal:  Molecules       Date:  2006-03-17       Impact factor: 4.411

9.  Synthesis of some new biologically active thiadiazolotriazinones--part III.

Authors:  B Shivarama Holla; B Sooryanarayana Rao; Richard Gonsalves; B K Sarojini; K Shridhara
Journal:  Farmaco       Date:  2002-08

10.  A novel potent radical scavenger, 8-(4-fluorophenyl)-2-((2E)-3-phenyl-2-propenoyl)-1,2,3,4-tetrahydropyrazolo[5,1-c] [1,2,4]triazine (FR210575), prevents neuronal cell death in cultured primary neurons and attenuates brain injury after focal ischemia in rats.

Authors:  Akinori Iwashita; Takuya Maemoto; Hirohisa Nakada; Ichiro Shima; Nobuya Matsuoka; Hiroshi Hisajima
Journal:  J Pharmacol Exp Ther       Date:  2003-10-08       Impact factor: 4.030

View more
  1 in total

1.  An Optimized Synthesis, Molecular Structure and Characterization of Benzylic Derivatives of 1,2,4-Triazin-3,5(2H,4H)-dione.

Authors:  Long-Chih Hwang; Shiun-Yau Yang; Chung-Lin Chuang; Gene-Hsiang Lee
Journal:  Molecules       Date:  2017-11-08       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.